Alexa
  • Directory of Taiwan

Johnson and Johnson drug approved to treat symptoms of autism in children

Johnson and Johnson drug approved to treat symptoms of autism in children

A Johnson & Johnson drug received expanded U.S. government approval Friday to treat aggression and other symptoms of autism in children.
The new use for Risperdal is to treat irritability associated with autistic disorder, including temper tantrums, deliberate self injury and aggression in children and adolescents, ages 5 to 16.
The approval is the first for the use of a drug to treat behaviors associated with autism in children, the Food and Drug Administration said.
Risperdal, first approved by the FDA in 1993, has been used to treat schizophrenia and bipolar disorder in adults.
The antipsychotic drug is not a cure for autism, nor does it treat the condition itself, but may provide relief for some children, according to Johnson & Johnson.
Autism is a complex developmental disability. It typically appears during a child's first three years of life, and affects communication, social interaction and creative or imaginative play.
In 2005, the FDA declined to expand its approval of Risperdal, also known as risperidone, to include autism.
The most common side effects of Risperdal include drowsiness, constipation, fatigue and weight gain.
___
On the Net:
http://www.fda.gov/


Updated : 2021-04-22 02:39 GMT+08:00